SBH Sciences

SBH Sciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

SBH Sciences is a long-established, privately-held biotech services and product company that functions as a specialized CRO and innovation hub. With over 28 years of operation, it has built a reputation for providing cost-effective, high-quality research tools (cytokines, antibodies, enzymes) and development services (bioassays, biomarker analysis) to the global biotech industry. Its unique 'SBH Hub' model combines CRO services, venture building, diagnostics, and incubation to accelerate client programs from discovery to IND, primarily serving startup companies and entrepreneurial scientists.

OncologyNeurologyMetabolicMuscleKidney

Technology Platform

Integrated suite for biologics development: proprietary recombinant cytokine/antibody manufacturing, extensive cell-based assay library (~400 cancer cell lines, >360 assays), and GLP-compliant biomarker/bioanalytical testing services.

Opportunities

Growing demand for specialized CRO services in biologics and cell therapy from capital-efficient virtual biotechs.
The integrated 'Hub' model allows SBH to capture value across the entire development chain, from incubation to clinical testing.
Expansion of venture-building activities offers potential equity-based returns on successful client programs.

Risk Factors

Revenue is dependent on the funding health and success of biotech clients, particularly startups, making it vulnerable to sector downturns.
Faces intense competition from large, global CROs and life science tool companies.
Operational complexity increases with the integrated 'Hub' model spanning multiple business units.

Competitive Landscape

SBH competes in the fragmented CRO and life science reagents market. It differentiates through deep specialization in cell-based assays and cytokines, a lean and cost-effective service model attractive to startups, and its unique integrated ecosystem that combines services, venture building, and incubation. Key competitors include large CROs (Charles River, LabCorp), specialty assay providers, and reagent manufacturers like PeproTech and R&D Systems.